Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
LOADING
|||
Debt to Equity Over Time
Trending higher, above historical average.
Left:
||||
Debt-to-equity ratio
Latest
0.01
↑ 113% above average
Average (5y)
-0.09
Historical baseline
Range
High:0.02
Low:-0.59
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 0.01 | +23.0% |
| 2023 | 0.01 | -47.0% |
| 2022 | 0.02 | - |
| 2021 | 0.00 | +100.0% |
| 2020 | -0.02 | +96.4% |
| 2019 | -0.59 | - |